Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2000
10/10/2000US6129896 Biosensor chip and manufacturing method
10/10/2000US6129895 Fuel additive analyzer system and process
10/10/2000US6129848 Such as blood components from whole blood sample, by agitating a mixture of the component and magnetic particles to attach one of the components; adding to a magnetic separation apparatus to capture magnetic particle-component
10/10/2000US6129825 Electrochemical gas sensor
10/10/2000US6129823 Low volume electrochemical sensor
10/10/2000US6129680 Animal exhalation monitoring
10/10/2000US6128962 Three-phase fluid flow measurement system and method
10/10/2000US6128949 Phase change analysis in logging method
10/10/2000US6128945 Gas detecting method and its detector
10/10/2000CA2265194C A method of testing the purity of lamotrigine
10/10/2000CA2204831C Fuel system low current rheostat
10/10/2000CA2196797C In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
10/10/2000CA2196790C 17q-linked breast and ovarian cancer susceptibility gene
10/10/2000CA2096417C Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy
10/10/2000CA2062969C Recombinantly produced human membrane cofactor protein (mcp)
10/10/2000CA2030516C Parathyroid hypertensive factor
10/10/2000CA2021581C Improved stable coagulation controls
10/10/2000CA2002839C Parvovirus capsids
10/10/2000CA1341113C Immunoassay for activator peptides
10/09/2000CA2304876A1 Methods for classifying samples and ascertaining previously unknown classes
10/08/2000CA2266760A1 Methylation of arginine and related amino acids
10/05/2000WO2000058734A1 Specific binding assay for docosahexaenoic acid
10/05/2000WO2000058733A2 Assay for testing the efficacity of a therapy
10/05/2000WO2000058732A1 Method for prediction of bone fractures by osteocalcin measurements
10/05/2000WO2000058731A1 Novel semiconductor nanoparticles for analysis of blood cell populations
10/05/2000WO2000058730A1 Method and device for detecting analytes in fluids
10/05/2000WO2000058729A2 Micromechanical antibody sensor
10/05/2000WO2000058728A1 Means of early examination of malignant tumor
10/05/2000WO2000058727A1 Single channel, single dilution detection method
10/05/2000WO2000058726A1 Method for quantitating leukocyte count in whole blood sample
10/05/2000WO2000058724A1 Microscale total analysis system
10/05/2000WO2000058688A1 Detection of chemicals using photo-induced and thermal bending in mems sensors
10/05/2000WO2000058522A1 Single nucleotide polymorphic discrimination by electronic dot blot assay on semiconductor microchips
10/05/2000WO2000058521A2 Methods for the identification of reporter and target molecules using comprehensive gene expression profiles
10/05/2000WO2000058520A1 Methods for identifying pathway-specific reporters and target genes, and uses thereof
10/05/2000WO2000058516A2 Universal arrays
10/05/2000WO2000058514A2 Methods for improving sensitivity and specificity of screening assays
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058506A2 Susceptibility to psoriasis
10/05/2000WO2000058504A1 High throughput screening method for determining enantioselectivity
10/05/2000WO2000058503A2 Improved method for detecting micro-organisms
10/05/2000WO2000058502A2 Use of collagenase 3 for detecting destructive diseases of the joints
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058477A1 Method for detecting mutation in hepatitis b virus and detection kit
10/05/2000WO2000058475A2 Streptococcus pneumoniae antigens
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058472A2 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same
10/05/2000WO2000058470A1 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer
10/05/2000WO2000058469A1 48 human secreted proteins
10/05/2000WO2000058468A2 47 human secreted proteins
10/05/2000WO2000058467A1 50 human secreted proteins
10/05/2000WO2000058462A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor proteins, bg3
10/05/2000WO2000058460A2 Casb619 involved in colon cancers
10/05/2000WO2000058455A2 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
10/05/2000WO2000058446A1 HUMAN PROTEIN KINASE Bη POLYPEPTIDES AND A METHOD FOR DISRUPTING PROTEIN KINASE Bη IN A NON-HUMAN
10/05/2000WO2000058443A1 Method for selectively separating blood cells by using lectin
10/05/2000WO2000058441A1 STAPHYLOCOCCUS AUREUS ydjB RELATED TO THE LUXS AUTOINDUCER SYNTHESIS FAMILY
10/05/2000WO2000058440A1 Diagnosis of whipple disease
10/05/2000WO2000058406A1 4,7-dichlororhodamine dyes useful as molecular probes
10/05/2000WO2000058405A2 Squaraine dyes
10/05/2000WO2000058364A1 Antibodies to placental protein 13
10/05/2000WO2000058363A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
10/05/2000WO2000058358A1 49 human secreted proteins
10/05/2000WO2000058357A1 50 human secreted proteins
10/05/2000WO2000058356A1 50 human secreted proteins
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058352A2 Barley gene for thioredoxin and nadp-thioredoxin reductase
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058340A2 50 human secreted proteins
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058336A1 50 human secreted proteins
10/05/2000WO2000058335A1 47 human secreted proteins
10/05/2000WO2000058334A1 50 human secreted proteins
10/05/2000WO2000058313A1 4-substituted quinoline derivatives as gaba receptor ligands
10/05/2000WO2000058303A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000WO2000058289A1 Halide indicators
10/05/2000WO2000058003A1 Method for preparing and screening catalysts
10/05/2000WO2000057915A1 Method of affecting cholesterol catabolism using nuclear bile acid receptor
10/05/2000WO2000057905A1 Recombinant neospora antigens and their uses
10/05/2000WO2000057903A2 48 human secreted proteins
10/05/2000WO2000057900A2 Factor for regulation of neurite growth
10/05/2000WO2000057899A1 Thrombospondin-2 and uses thereof
10/05/2000WO2000057896A1 Modulators of polysaccharides and uses thereof
10/05/2000WO2000057837A2 Compositions and methods for effecting the levels of cholesterol
10/05/2000WO2000057827A1 Single-use hygiene items
10/05/2000WO2000057756A1 Ultrasonic force differentiation assay
10/05/2000WO2000031258A3 Human orphan g protein-coupled receptors
10/05/2000WO2000031133A3 Potassium channel interactors and uses therefor
10/05/2000WO2000029574A3 Inflammation-associated genes
10/05/2000WO2000029433A3 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines
10/05/2000WO2000028297A3 A method for the assessment of particles and a system and a device for use in the method
10/05/2000WO2000028039A3 Identification of senv genotypes
10/05/2000WO2000026246A3 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
10/05/2000WO2000022437A9 Prognostic method for anti-resorptive treatment
10/05/2000WO2000022130A3 Metastatic breast and colon cancer regulated genes
10/05/2000WO2000020638A9 Methods and compositions for the diagnosis and therapy of prostate cancer
10/05/2000WO2000020625A9 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction
10/05/2000WO2000013003A9 Optical-based sensing devices
1 ... 3067 3068 3069 3070 3071 3072 3073 3074 3075 3076 3077 3078 3079 3080 3081 3082 3083 3084 3085 3086 3087 ... 3937